HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.

AbstractINTRODUCTION:
Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a pathologic condition of increasing frequency, with a poorly understood pathophysiology and which can be difficult to manage. The aim of this study was to find a reproducible experimental model that directly relates chronic bisphosphonate administration with the development of osteonecrosis with or without tooth extraction, with no other drug involved.
MATERIAL AND METHODS:
Twenty male Wistar rats were divided into 4 groups (n = 5/group). Animals were injected over 9 weeks with zoledronic acid (0.1 mg/kg). In groups 1 and 2 three times a week intraperitoneally, and in group 3 once a week intravenously. A control group (group 4) received intraperitoneal injections of saline solution three times a week. After 8 weeks of treatment, 3 right upper jaw molars were extracted in groups 1, 3 and 4 and all rats were sacrificed 1 week later. The maxillae were histologically analyzed for presence of osteonecrosis foci, number of osteoclasts, vascularity, bone resorption status and presence of abscess. Radiographic examination was performed with a plain radiograph of each hemi-head.
RESULTS:
We found that group 1 (dental extractions and highest cumulative dose of zoledronic acid) had the highest incidence of osteonecrosis (80%), absence of bone resorption (100%) and lowest number of osteoclasts (mean 7.9/field at 40×). Zoledronic acid-treated groups showed variable degrees of osteosclerosis and trabecular disorganization on X-ray study.
CONCLUSIONS:
We offer a new animal model of BRONJ after zoledronic acid administration and dental extractions, achieving bone changes similar or superior to previous studies, highlighting the dental extraction as an important trigger factor.
AuthorsPaula Barba-Recreo, Jose Luis Del Castillo Pardo de Vera, Mariano García-Arranz, Laura Yébenes, Miguel Burgueño
JournalJournal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery (J Craniomaxillofac Surg) Vol. 42 Issue 6 Pg. 744-50 (Sep 2014) ISSN: 1878-4119 [Electronic] Scotland
PMID24342733 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
Topics
  • Abscess (etiology, pathology)
  • Alveolar Process (blood supply, pathology)
  • Animals
  • Bisphosphonate-Associated Osteonecrosis of the Jaw (etiology, pathology)
  • Bone Density (drug effects)
  • Bone Density Conservation Agents (administration & dosage, adverse effects)
  • Bone Resorption (etiology, pathology)
  • Diphosphonates (administration & dosage, adverse effects)
  • Disease Models, Animal
  • Imidazoles (administration & dosage, adverse effects)
  • Injections, Intraperitoneal
  • Injections, Intravenous
  • Male
  • Maxilla (blood supply, pathology, surgery)
  • Molar (surgery)
  • Osteoclasts (pathology)
  • Osteosclerosis (etiology, pathology)
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Tooth Extraction (adverse effects)
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: